Accueil   Diary - News   All news Biom'Up completes the first of its financing operations for a total amount of more than €40 million

Biom’Up completes the first of its financing operations for a total amount of more than €40 million

  • €16 million capital increase completed successfully by means of a public offering without preferential subscription rights
  • Biom'Up aims to complete its second financing transaction by finalizing, as soon as possible, a bond issue with Athyrium Capital
  • Management for an initial amount of €25 million which may subsequently be increased to €35 million
  • The proposed bond issue will enable the company to refinance the Kreos Capital loan of €8.2 million

     

 

 

 

Saint-Priest, France, February 20, 2018 – 7.00 a.m. Paris time – Biom’Up (the “Company”), a specialist in surgical hemostasis, announces today the success of its capital increase without preferential subscription rights for shareholders by means of a public offering and with a priority subscription period, as of right only, for existing shareholders (the “Offering”), in a total amount (including additional paid-in capital) of €16 million. Athyrium Capital Management (“Athyrium”) has confirmed it is participating in the Offering and efforts are underway to finalize the €25 million bond issue (the “Bond Issue”) with stock warrants, the size of which may subsequently be increased to €35 million.

 

Read the press release

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree